Literature DB >> 10746848

Prognostic significance of serous and clear cell adenocarcinoma in surgically staged endometrial carcinoma.

N Sakuragi1, H Hareyama, Y Todo, H Yamada, R Yamamoto, T Fujino, T Sagawa, S Fujimoto.   

Abstract

BACKGROUND: The serous adenocarcinoma (SA) and clear cell adenocarcinoma (CCA) of endometrium have been shown to be associated with high relapse rate and poor survival. It is not clear whether prognostic significance of these specific cell types of tumor is independent of retroperitoneal lymph node metastasis and other histopathologic prognostic factors in endometrial carcinoma.
METHODS: We examined 240 consecutive patients with clinical stage I to stage III endometrial carcinoma who were treated prospectively with radical surgery and/or platinum-based chemotherapy. Surgery included extended hysterectomy, bilateral salpingo-oophorectomy, and systematic pelvic and paraaortic lymph node dissection. Prognostic significance of various histopathologic factors was determined by Cox regression analysis.
RESULTS: SA/CCA were more frequently associated with deep myometrial invasion, high nuclear grade (G3), lymph-vascular space invasion (LVSI), and pelvic lymph node metastasis when compared to endometrioid adenocarcinoma (EMA). Of 216 clinically staged stage I or II disease, seven of 12 cases of SA/CCA had extrauterine disease. This incidence was much higher than that for EMA (46/204) (p<0.01). A multivariate Cox regression analysis revealed that cell type, grade, LVSI, and paraaortic node metastasis (PANM) were independent prognosticators.
CONCLUSIONS: Prognosis of patients with endometrial carcinoma depends on cell type, grade, LVSI, and PANM. Poor prognosis for patients with SA/CCA is independent of lymph node metastasis and other histopathologic prognostic factors. The SA/CCA should be strictly discriminated from EMA.

Entities:  

Mesh:

Year:  2000        PMID: 10746848

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  5 in total

1.  Comparison of outcomes in early-stage uterine clear cell carcinoma and serous carcinoma.

Authors:  Minsi Zhang; T Jonathan Yang; Neil B Desai; Deborah DeLair; Marisa A Kollmeier; Vicky Makker; Mario M Leitao; Nadeem R Abu-Rustum; Kaled M Alektiar
Journal:  Brachytherapy       Date:  2018-10-10       Impact factor: 2.362

2.  The effect of cell type on surgico-pathologic risk factors in endometrial cancer.

Authors:  Ahmet Taner Turan; Betül Dündar; Burcu Gündoğdu; Abdullah Boztosun; Nejat Ozgül; Nurettin Boran; Gökhan Tulunay; Ahmet Ozfuttu; Mehmet Faruk Köse
Journal:  J Turk Ger Gynecol Assoc       Date:  2011-03-01

3.  miR-214-3p inhibits epithelial-to-mesenchymal transition and metastasis of endometrial cancer cells by targeting TWIST1.

Authors:  Yuan-Yuan Fang; Ming-Rong Tan; Jian Zhou; Li Liang; Xiao-Yun Liu; Kun Zhao; Er-Chen Bao
Journal:  Onco Targets Ther       Date:  2019-11-18       Impact factor: 4.147

4.  microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathway.

Authors:  Takashi Mitamura; Hidemichi Watari; Lei Wang; Hiromi Kanno; Makiko Kitagawa; Mohamed Kamel Hassan; Taichi Kimura; Mishie Tanino; Hiroshi Nishihara; Shinya Tanaka; Noriaki Sakuragi
Journal:  Mol Cancer       Date:  2014-04-29       Impact factor: 27.401

5.  The correlation between microRNA490-3p and TGFα in endometrial carcinoma tumorigenesis and progression.

Authors:  Kai-Xuan Sun; Ying Chen; Shuo Chen; Bo-Liang Liu; Miao-Xiao Feng; Zhi-Hong Zong; Yang Zhao
Journal:  Oncotarget       Date:  2016-02-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.